Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment. Conjugated to CF™488, it shows less non-specific binding and less red spill-over than traditional rhodamine chemistry.
